End-of-day quote
Other stock markets
|
||
- USD | - |
05-17 | UBS Adjusts Price Target on Hercules Capital to $18.50 From $18, Maintains Neutral Rating | MT |
05-15 | Adaptimmune Therapeutics Enters Into $125 Million Term Loan Facility With Hercules Capital | MT |